High-Quality Acute Myeloid Leukemia PBMC for Research

Acute Myeloid Leukemia (AML) PBMC products are sourced from donors clinically diagnosed with acute myeloid leukemia (AML) and processed under stringent conditions to support immune response in oncology research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on immune response and biomarker identification.

Product Features

• Research Use Only (RUO), cryopreserved AML PBMC Samples
• Clinically confirmed AML donors
• Processed within 24 hours of collection
• Stored using CryoStore® CS10 freezing media
• IRB-approved protocols and electronic informed consent

Donor Metadata

• Verified AML diagnosis
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Self-reported allergies and infectious disease history
• Additional acute myeloid leukemia (aml)-specific data available upon request

Applications

• Biomarker discovery and validation
• Drug screening and therapeutic development
• Immune pathway analysis in AML pathophysiology
• Transcriptomic and proteomic profiling

Quality and Compliance

• IRB-approved collections and protocols
• 21 CFR Part 11 – compliant e-consent system
• HIPAA-compliant donor data protection

Ordering & Shipping

Acute Myeloid Leukemia PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.